Literature DB >> 25590240

PCDH10, a novel p53 transcriptional target in regulating cell migration.

Dingding Shi1, Vundavalli V Murty, Wei Gu.   

Abstract

Cell cycle arrest, senescence and apoptosis are commonly regarded as the major tumor suppression mechanisms of p53. However, accumulating evidence indicates that loss of these canonical functions is not sufficient for tumor formation, highlighting the complexity of p53-mediated tumor suppression. PCDH10 belongs to a proto cadherin protein family and is a potential tumor suppressor protein as the dysregulation of PCDH10 gene frequently existed in multiple human tumors. Here, we found that PCDH10 is a transcriptional target of p53 and that the levels of PCDH10 expression can be induced by wild type p53 but not mutant p53 in a number of human cancer cell lines. Moreover, we identified a p53 consensus binding site located in the PCDH10 promoter region that is responsive to p53 regulation. Although upregulation of PCDH10 has no obvious effect on growth arrest or apoptosis in human cells, PCDH10 exhibits inhibitory roles in cancer cell motility and cell migration. These results suggest an important role of p53 in regulating tumor cell migration through activating PCDH10 expression and support the notion that non-canonical activities of p53 may contribute to its tumor suppressor function in vivo.

Entities:  

Keywords:  PCDH10; apoptosis and cell migration; cell cycle arrest; p53; senescence

Mesh:

Substances:

Year:  2015        PMID: 25590240      PMCID: PMC4615063          DOI: 10.1080/15384101.2015.1004935

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  30 in total

1.  Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.

Authors:  Tongyuan Li; Ning Kon; Le Jiang; Minjia Tan; Thomas Ludwig; Yingming Zhao; Richard Baer; Wei Gu
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

2.  Tumor suppression by p53: fall of the triumvirate?

Authors:  Andreas K Hock; Karen H Vousden
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

3.  Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.

Authors:  J Ying; H Li; T J Seng; C Langford; G Srivastava; S W Tsao; T Putti; P Murray; A T C Chan; Q Tao
Journal:  Oncogene       Date:  2006-02-16       Impact factor: 9.867

4.  Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression.

Authors:  Song Fang; Shi-feng Huang; Ju Cao; Yang-an Wen; Li-Ping Zhang; Guo-Sheng Ren
Journal:  Clin Exp Med       Date:  2012-04-29       Impact factor: 3.984

5.  Mutant p53 drives invasion by promoting integrin recycling.

Authors:  Patricia A J Muller; Patrick T Caswell; Brendan Doyle; Marcin P Iwanicki; Ee H Tan; Saadia Karim; Natalia Lukashchuk; David A Gillespie; Robert L Ludwig; Pauline Gosselin; Anne Cromer; Joan S Brugge; Owen J Sansom; Jim C Norman; Karen H Vousden
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

6.  Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.

Authors:  Gopeshwar Narayan; Luigi Scotto; Vijayalakshmi Neelakantan; Sherine H Kottoor; Ada Ho Yan Wong; Shee-Loong Loke; Mahesh Mansukhani; Bhavana Pothuri; Jason D Wright; Andreas M Kaufmann; Achim Schneider; Hugo Arias-Pulido; Qian Tao; Vundavalli V Murty
Journal:  Genes Chromosomes Cancer       Date:  2009-11       Impact factor: 5.006

7.  Multiple autism-linked genes mediate synapse elimination via proteasomal degradation of a synaptic scaffold PSD-95.

Authors:  Nien-Pei Tsai; Julia R Wilkerson; Weirui Guo; Marina A Maksimova; George N DeMartino; Christopher W Cowan; Kimberly M Huber
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

8.  Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer.

Authors:  Jian-Guo Ma; Zheng-Kai He; Jian-Hua Ma; Wen-Ping Li; Guang Sun
Journal:  J Int Med Res       Date:  2013-01-23       Impact factor: 1.671

9.  Forkhead transcription factor FOXF1 is a novel target gene of the p53 family and regulates cancer cell migration and invasiveness.

Authors:  M Tamura; Y Sasaki; R Koyama; K Takeda; M Idogawa; T Tokino
Journal:  Oncogene       Date:  2013-11-04       Impact factor: 9.867

Review 10.  p53 and its mutants in tumor cell migration and invasion.

Authors:  Patricia A J Muller; Karen H Vousden; Jim C Norman
Journal:  J Cell Biol       Date:  2011-01-24       Impact factor: 10.539

View more
  9 in total

1.  Epigenetic silencing of protocadherin 10 in colorectal cancer.

Authors:  Xian Zhong; Hong Shen; Jianshan Mao; Jiawei Zhang; Weidong Han
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

2.  WDR63 inhibits Arp2/3-dependent actin polymerization and mediates the function of p53 in suppressing metastasis.

Authors:  Kailiang Zhao; Decai Wang; Xiaolong Zhao; Chenfeng Wang; Yongxiang Gao; Kaiyue Liu; Fang Wang; Xianning Wu; Xuejuan Wang; Linfeng Sun; Jianye Zang; Yide Mei
Journal:  EMBO Rep       Date:  2020-03-04       Impact factor: 8.807

3.  Prognostic signature of protocadherin 10 methylation in curatively resected pathological stage I non-small-cell lung cancer.

Authors:  Hiroaki Harada; Kazuaki Miyamoto; Yoshinori Yamashita; Kiyomi Taniyama; Kazuko Mihara; Mitsuki Nishimura; Morihito Okada
Journal:  Cancer Med       Date:  2015-08-15       Impact factor: 4.452

4.  MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10.

Authors:  Ying Qi; Hong Sain Ooi; Jun Wu; Jian Chen; Xiaoli Zhang; Sheng Tan; Qing Yu; Yuan-Yuan Li; Yani Kang; Hua Li; Zirui Xiong; Tao Zhu; Bingya Liu; Zhifeng Shao; Xiaodong Zhao
Journal:  Oncotarget       Date:  2016-03-15

5.  Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer.

Authors:  Wentao Liu; Jin Wu; Guangyue Shi; Xiaolong Yue; Dan Liu; Qingyuan Zhang
Journal:  Oncol Lett       Date:  2018-07-25       Impact factor: 2.967

6.  Do Protocadherins Show Prognostic Value in the Carcinogenesis of Human Malignant Neoplasms? Systematic Review and Meta-Analysis.

Authors:  Thaís Torres Barros Dutra; Thâmara Manoela Marinho Bezerra; Ealber Carvalho Macêdo Luna; Francisco Samuel Rodrigues Carvalho; Filipe Nobre Chaves; Paulo Goberlânio De Barros Silva; Fábio Wildson Gurgel Costa; Karuza Maria Alves Pereira
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01

7.  Innovative mouse models for the tumor suppressor activity of Protocadherin-10 isoforms.

Authors:  Irene Kleinberger; Ellen Sanders; Katrien Staes; Marleen Van Troys; Shinji Hirano; Tino Hochepied; Kelly Lemeire; Liesbet Martens; Christophe Ampe; Frans van Roy
Journal:  BMC Cancer       Date:  2022-04-25       Impact factor: 4.638

8.  Promoter methylation of PCDH10 by HOTAIR regulates the progression of gastrointestinal stromal tumors.

Authors:  Na Keum Lee; Jung Hwa Lee; Won Kyu Kim; Seongju Yun; Young Hoon Youn; Chan Hyuk Park; Yun Young Choi; Hogeun Kim; Sang Kil Lee
Journal:  Oncotarget       Date:  2016-11-15

9.  The Monoclonal Antibody Recognized the Open Reading Frame Protein in Porcine Circovirus Type 2-Infected Peripheral Blood Mononuclear Cells.

Authors:  Ling-Chu Hung
Journal:  Viruses       Date:  2020-08-29       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.